PulseAugur
EN
LIVE 17:47:12
ENTITY chemotherapy

chemotherapy

PulseAugur coverage of chemotherapy — every cluster mentioning chemotherapy across labs, papers, and developer communities, ranked by signal.

Show in brief
Total · 30d
2
4 over 90d
Releases · 30d
0
0 over 90d
Papers · 30d
1
2 over 90d
TIER MIX · 90D
TOPICS
SENTIMENT · 30D

2 day(s) with sentiment data

RECENT · PAGE 1/1 · 7 TOTAL
  1. TOOL · CL_254142 ·

    AI model predicts personalized chemosensitivity for breast cancer treatment

    Researchers have developed a causal multi-modal AI model designed to predict individual patient chemosensitivity for breast cancer treatment. This AI approach utilizes routinely collected pathology and clinical data to …

  2. RESEARCH · CL_248753 ·

    FDA approves new cancer drug targeting difficult RAS protein

    The FDA has approved daraxonrasib, a new medication designed to target RAS, a difficult-to-treat protein implicated in various cancers. This drug has shown significant promise in clinical trials for metastatic pancreati…

  3. TOOL · CL_188046 ·

    Ultrasound tech opens blood-brain barrier for CNS drug delivery

    Openwater, a company focused on ultrasound technology, is advancing its use in drug delivery for neurological conditions like Alzheimer's and Parkinson's. Their method utilizes low-intensity focused ultrasound with micr…

  4. RESEARCH · CL_145701 ·

    AI-powered digital twins enhance brain tumor prediction and treatment

    Researchers have developed an AI-augmented adaptive digital twin framework to predict brain tumor evolution and optimize treatment schedules. This framework integrates a reaction-diffusion model with a 3D residual learn…

  5. TOOL · CL_85832 ·

    New targeted drug offers improved outcomes for aggressive breast cancer

    A new antibody-drug conjugate has shown promising results in a clinical trial for aggressive triple-negative breast cancer. The targeted therapy, which combines an antibody with chemotherapy, significantly extended prog…

  6. TOOL · CL_66946 ·

    New targeted drug shrinks uterine cancer tumors in clinical trial

    A novel antibody-drug conjugate has shown promise in treating advanced uterine cancer, shrinking tumors and slowing disease progression in a recent clinical trial. This targeted therapy delivers chemotherapy directly to…

  7. COMMENTARY · CL_49262 ·

    AI development needs chemotherapy-like regulation and trials

    The analogy between AI and chemotherapy suggests that dismissing AI entirely due to its side effects is shortsighted. Just as chemotherapy, despite its drawbacks, offers curative and management benefits for certain canc…